Fiji vs Togo: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Togo
100.0%
in 2024
Fiji rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Togo
How they compare
Fiji currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 10 times across 16 shared years of data; in 2007 it was Togo ahead.
Fiji ranks 1st and Togo ranks 1st of 180 countries.
Across the 3 decades both report, Fiji averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Fiji | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 8.9% | 41.0% | Fiji |
| 2010s | 49.8% | 61.3% | 11.5% | Togo |
| 2020s | 81.8% | 92.2% | 10.4% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Togo?
- Fiji, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Togo?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Togo?
- 16 years are reported by both, from 2007 to 2024.
- How do Fiji and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.